Halozyme Therapeutics, Inc.
11388 Sorrento Valley Road
San Diego
California
92121
United States
Tel: 858-794-8889
Fax: 858-259-2539
Website: http://www.halozyme.com/
Email: hr@halozyme.com
575 articles about Halozyme Therapeutics, Inc.
-
Halozyme Therapeutics, Inc. Reports Fourth Quarter and Year End 2007 Financial Results
3/14/2008
-
Halozyme Therapeutics, Inc. Presents Favorable New Safety and Pharmacokinetic Data on rHuPH20 Enzyme Produced Via New Manufacturing Process
3/11/2008
-
Halozyme Therapeutics, Inc. to Hold Pipeline Update Conference Call on March 14
3/7/2008
-
Halozyme Therapeutics, Inc. to Present at the Biotechnology Industry Organization (BIO) CEO and Investor Conference and the Roth Growth Stock Conference
2/5/2008
-
Halozyme Therapeutics, Inc. Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
1/8/2008
-
Halozyme Therapeutics, Inc. to Present at Lazard Capital Markets Fourth Annual Healthcare Conference
11/19/2007
-
Halozyme Therapeutics, Inc. Amends Stockholder Rights Plan
11/15/2007
-
Halozyme Therapeutics, Inc. Names Matthew R. Hooper Vice President, General Counsel
11/14/2007
-
Halozyme Therapeutics, Inc. Added to Nasdaq Biotech Index
11/13/2007
-
Halozyme Therapeutics, Inc. Reports 2007 Third Quarter Financial Results
11/9/2007
-
Halozyme Therapeutics, Inc. to Hold Business Update Conference Call on November 9
11/2/2007
-
Halozyme Therapeutics, Inc. Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
9/26/2007
-
Halozyme Therapeutics, Inc. to Present at UBS Warburg 2007 Global Life Sciences Conference
9/14/2007
-
Baxter International, Inc. (Jobs) and Halozyme Therapeutics, Inc. (Jobs) Announce Collaboration for Development of Subcutaneous GAMMAGARD LIQUID(TM) Administration Using Enhanze(TM) Technology
9/10/2007
-
Halozyme Therapeutics, Inc. to Present at Roth Capital Partners 2007 New York Conference
8/28/2007
-
Halozyme Therapeutics, Inc. to Hold Business Update Conference Call on August 10
8/2/2007
-
Halozyme Therapeutics, Inc. Names Walter H. Bee, PhD Vice President, Preclinical Development
7/17/2007
-
Halozyme Therapeutics, Inc. to Present at the Jefferies Healthcare Conference
6/20/2007
-
Halozyme Therapeutics, Inc. Announces Closing of $32.1 Million Private Financing
5/31/2007
-
Halozyme Therapeutics, Inc. Reports 2007 First Quarter Financial Results
5/11/2007